报价延迟最少15分钟:2025/01/12 06:59 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
11.4 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.63/--
|
|
企业价值
116.69M
|
| 资产负债 |
|
每股账面净值
-0.38
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/01/12 06:59 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Invizyne Technologies Inc is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought-after chemicals. It believes that its biomanufacturing platform, known as SimplePath, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology. its objective with SimplePath isto enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform consists of a series of modular cascading enzyme-based biomanufacturing systems that leverage natural processes to perform complex chemical conversions. |